Record NNP B-NP O
date NN I-NP O
: : O O
2124-03-01 CD O B-DATE
Problems NNS B-NP O
Diabetes NNP B-NP O
mellitus NN I-NP O
type NN I-NP O
2 CD I-NP O
: : O O
10/20 CD O B-DATE
Hyperlipidemia NNP B-NP O
: : O O
10/20 CD O B-DATE
Smoking VBG O O
sp NN B-NP O
oral JJ I-NP O
cancer NN I-NP O
: : O O
6/21 CD O B-DATE
Thyroid NNP B-NP O
nodule NN I-NP O
cad NN B-NP O
stent NN B-NP O
placement NN I-NP O
Medications NNS B-NP O
Aspirin NNP B-NP O
(ACETYLSALICYLIC NN I-NP O
ACID NNP I-NP O
) -RRB- I-NP O
325 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
325MG JJ I-NP O
TABLET NN I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QD . O O
Atenolol NNP B-NP O
50MG CD I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Lipitor NNP B-NP O
( -LRB- I-NP O
ATORVASTATIN NNP I-NP O
) -RRB- I-NP O
80 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
80MG NN I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
QD IN B-PP O
# # B-NP O
30 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Nitroglycerin NNP B-NP O
1/200 CD I-NP O
( -LRB- I-NP O
0.3 CD I-NP O
MG) NN I-NP O
1 CD I-NP O
TAB NNP I-NP O
SL NNP I-NP O
as IN B-PP O
directed VBN B-NP O
PRN NNP I-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
1 CD B-NP O
Q NN I-NP O
5 CD B-NP O
minutes NNS I-NP O
X NNP B-NP O
3 CD I-NP O
prn NN I-NP O
Plavix NNP B-NP O
( -LRB- I-NP O
CLOPIDOGREL NN I-NP O
) -RRB- I-NP O
75 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
75MG NNP I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QD . O O
Zestril NNP B-NP O
( -LRB- I-NP O
LISINOPRIL NNP I-NP O
) -RRB- I-NP O
10 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
10MG VBD I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NNP I-NP O
QD NNP B-PP O
# # B-NP O
30 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Allergies . O O
Tetracycline NNP B-NP O
Hcl NNP I-NP O
- : O O
headache NN B-NP O
, , O O
: : O O
Vital JJ B-NP O
Signs NNS I-NP O
BP NNP B-NP O
170/80 CD I-NP O
, , O O
P NNP B-NP O
64 CD I-NP O
O2 IN B-PP O
SAT NNP B-NP O
98 CD I-NP O
Comes NNS B-NP O
in IN B-PP O
today NN B-NP O
after IN B-PP O
stent NN B-NP O
pacement NN I-NP O
no DT B-NP O
chest NN I-NP O
pain NN I-NP O
walks NNS B-NP O
not RB B-ADJP O
strict JJ I-ADJP O
with IN B-PP O
diabetes NNS B-NP O
to TO B-PP O
date NN B-NP O
chest NN B-NP O
clear JJ I-NP O
hs NNS B-NP O
1,2 CD B-NP O
carotids NNS B-NP O
ok NN I-NP O
no DT B-NP O
nodes NNS I-NP O
abdo NN B-NP O
nad NN I-NP O
pulses NNS B-NP O
present NN I-NP O
Reinforced VBN B-VP O
the DT B-NP O
need NN I-NP O
for IN B-PP O
tight JJ B-NP O
control NN I-NP O
of IN B-PP O
her PRP$ B-NP O
diabetes NNS I-NP O
, , I-NP O
bp NN I-NP O
and CC I-NP O
lipids NNS I-NP O
given VBN B-VP O
her PRP$ B-NP O
recent JJ I-NP O
cad NN I-NP O
will MD O O
add VB B-VP O
metformin NN B-NP O
bid NN I-NP O
increase NN B-NP O
zestril NN I-NP O
20mg . O O
may MD B-VP O
be VB I-VP O
able JJ B-ADJP O
to TO B-VP O
reduce VB I-VP O
dose NN B-NP O
of IN B-PP O
lipitor NN B-NP O
to TO B-PP O
40 CD B-NP O
mg NN I-NP O
if IN B-PP O
target NN B-NP O
ldl NN I-NP O
of IN B-PP O
70 CD B-NP O
is VBZ B-VP O
reached VBN I-VP O
tcb NN B-NP O
6/67 CD I-NP B-DATE
